TD Waterhouse Canada’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
TD Waterhouse Canada's NVS Position: Q2 2026 in Review
TD Waterhouse Canada increased its Novartis (NVS) stake by 16% in Q2 2026, buying an estimated $1.77M and bringing the position to 86,457 shares worth $13.3M. The position accounts for 0.04% of the portfolio, ranked #239.
TD Waterhouse Canada first reported a position in NVS in Q4 2021 and has held it in 19 quarters since. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- TD Waterhouse Canada held 86,457 shares of Novartis worth $13.3M as of Q2 2026.
- TD Waterhouse Canada bought 11,791 Novartis shares in Q2 2026, an estimated $1.77M.
- Novartis made up 0.04% of TD Waterhouse Canada's portfolio in Q2 2026, its #239 holding.
- TD Waterhouse Canada first reported a position in Novartis in Q4 2021 and has held it in 19 quarters since.
- 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.